A detailed history of Jefferies Financial Group Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 275,000 shares of SWTX stock, worth $11.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
275,000
Holding current value
$11.8 Million
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $8.81 Million - $11.8 Million
275,000 New
275,000 $8.81 Million
Q1 2024

May 13, 2024

SELL
$36.5 - $52.5 $10.5 Million - $15.1 Million
-287,411 Reduced 80.72%
68,667 $3.38 Million
Q4 2023

Feb 13, 2024

BUY
$18.94 - $37.24 $6.74 Million - $13.3 Million
356,078 New
356,078 $13 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.68B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.